These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2677929)

  • 41. A multicenter, open comparative study of parenteral cefotaxime and ceftriaxone in the treatment of nosocomial lower respiratory tract infections.
    Garber GE; Auger P; Chan RM; Conly JM; Shafran SD; Gerson M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):85-8. PubMed ID: 1730189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No significant difference between ceftriaxone and cefotaxime in the emergence of antibiotic resistance in the gut microbiota of hospitalized patients: A pilot study.
    Pilmis B; Jiang O; Mizrahi A; Nguyen Van JC; Lourtet-Hascoët J; Voisin O; Le Lorc'h E; Hubert S; Ménage E; Azria P; Borie MF; Mahé A; Mourad JJ; Trabattoni E; Ganansia O; Zahar JR; Le Monnier A
    Int J Infect Dis; 2021 Mar; 104():617-623. PubMed ID: 33453395
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
    Kim KS; Bayer AS
    Antimicrob Agents Chemother; 1985 Jul; 28(1):51-4. PubMed ID: 3899006
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antibiotic and specific immunoglobulin G in the treatment of E. coli sepsis in mice previously given steroids].
    Bakir M; Doğanay M; Dökmetaş I
    Mikrobiyol Bul; 1990 Oct; 24(4):336-43. PubMed ID: 2287291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of ceftriaxone and its relation to concentrations in extravascular compartments. Comparison with cefotaxime.
    Regamey C
    Chemotherapy; 1985; 31(2):85-94. PubMed ID: 3987394
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic prophylaxis in the surgical treatment of peritrochanteric fractures: a comparative trial between two cephalosporins.
    Karachalios T; Lyritis GP; Hatzopoulos E
    Chemotherapy; 1990; 36(6):448-53. PubMed ID: 2292207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of cefotaxime with ceftriaxone given intramuscularly 12-hourly for community-acquired pneumonia.
    Dansey RD; Jacka PJ; Strachan SA; Hay M
    Diagn Microbiol Infect Dis; 1992 Jan; 15(1):81-4. PubMed ID: 1730188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of ceftriaxone with cefotaxime in serious chest infections.
    Reeves JH; Russell GM; Cade JF; McDonald M
    Chest; 1989 Dec; 96(6):1292-7. PubMed ID: 2684552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of cefotaxime and ceftriaxone on the bowel and vaginal flora after single-dose prophylaxis in vaginal hysterectomy.
    Bräutigam HH; Knothe H; Rangoonwala R
    Drugs; 1988; 35 Suppl 2():163-8. PubMed ID: 3135167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The histopathological effects of different treatments on lung tissue of mice pretreated with cyclophosphamide and steroids in experimental E. coli sepsis].
    Düzcan E; Bakir M; Dökmetaş I; Doğanay M; Güneş H
    Mikrobiyol Bul; 1991 Oct; 25(4):349-59. PubMed ID: 1795659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of different classes antimicrobial agents on plasma endotoxin activity.
    Nitsche D; Schulze C; Oesser S; Dalhoff A; Sack M
    Arch Surg; 1996 Feb; 131(2):192-9. PubMed ID: 8611078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time course of the pharmacological response to beta-lactam antibiotics in vitro and in vivo.
    Gerber AU; Feller C; Brugger HP
    Eur J Clin Microbiol; 1984 Dec; 3(6):592-7. PubMed ID: 6098475
    [No Abstract]   [Full Text] [Related]  

  • 54. Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.
    Martin E
    Eur J Clin Microbiol; 1983 Oct; 2(5):509-15. PubMed ID: 6315428
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults. Meropenem Meningitis Study Group.
    Schmutzhard E; Williams KJ; Vukmirovits G; Chmelik V; Pfausler B; Featherstone A
    J Antimicrob Chemother; 1995 Jul; 36 Suppl A():85-97. PubMed ID: 8543502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of experimental ascending Escherichia coli pyelonephritis with ceftriaxone alone and in combination with gentamicin.
    Glauser MP; Bonard
    Chemotherapy; 1982; 28(5):410-6. PubMed ID: 6291870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Quantitative study of capillary and venous bacterial diffusion in experimental bacteremia in chickens].
    Labarthe JC; Guillot JF; Brée A; Mouline C
    Ann Inst Pasteur Microbiol; 1986; 137B(3):317-24. PubMed ID: 3318872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ceftriaxone vs cefotaxime for treatment of Haemophilus influenzae meningitis.
    Madson L; Grose C
    Pediatrics; 1990 Apr; 85(4):622-4. PubMed ID: 2314980
    [No Abstract]   [Full Text] [Related]  

  • 59. Short-course treatment of bacteremia with ceftriaxone monotherapy.
    Wang LS; Cheng DL; Hinthorn DR; Liu C; Fung CP; O'Connor MC
    J Formos Med Assoc; 1990 Feb; 89(2):115-20. PubMed ID: 1973718
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
    Burdet C; Grall N; Linard M; Bridier-Nahmias A; Benhayoun M; Bourabha K; Magnan M; Clermont O; d'Humières C; Tenaillon O; Denamur E; Massias L; Tubiana S; Alavoine L; Andremont A; Mentré F; Duval X;
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30936104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.